Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2017-07-05

Clinical Trial Update: Phosphodiesterase 5 Inhibitors (PDE5i) (Sildenafil) as Medical Expulsive Therapy in Distal Ureteral Stones [Phase 4]

View source ↗

Summary

This clinical trial update describes a Phase 4 study evaluating sildenafil as medical expulsive therapy for distal ureteral stones (ureteral stone/urolithiasis)…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • SILDENAFIL (SILDENAFIL)

Snippet

Sponsor: Mansoura University | Conditions: Ureteral Stone, Urolithiasis | Phase 4 | Status: UNKNOWN